Parameter | ITT Population (N = 126) | PP Population (N = 93) | ||
---|---|---|---|---|
Darbepoetin alfa (n = 63) | Erythropoietin alfa (n = 63) | Darbepoetin alfa (n = 47) | Erythropoietin alfa (n = 46) | |
Number of weeks to initially attain target Hb | ||||
Median (95%CI) | 9.00 (7.00–11.00) | 7.00 (4.00–9.00) | 9.00 (7.00–10.00) | 7.00 (4.00–8.00) |
No. of Patients initially attained target Hb level | ||||
N (%) | 44 (78.57) | 43 (82.69) | 40 (85.10) | 41 (89.13) |
Hazard Ratio (95%CI) | 0.807 (0.53–1.23) | 0.778 (0.50–1.21) | ||
P Value | 0.3212 | 0.2608 | ||
No. of patients attained target Hb level at EOC | ||||
N (%) | 33 (52.38) | 31 (49.2) | 32 (68.08) | 32 (69.56) |
Odd ratios (95%CI) | 0.9559 (0.46–1.99) | 0.9410 (0.39–2.30) | ||
P value | 0.9038 | 0.8938 | ||
No. of patients maintained target Hb level at EOM | ||||
(%) | 24 (38.10) | 36 (57.14) | 15 (34.09) | 23 (57.50) |
Odd ratios (95%CI) | 0.5748 (0.26–1.25) | 0.4567 (0.17–1.22) | ||
P Value | 0.1621 | 0.1180 |